Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
25.37
-0.06 (-0.24%)
Nov 21, 2024, 1:44 PM EST - Market open
Enliven Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$36.75
Upside
+44.86%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $32 → $40 | Buy | Maintains | $32 → $40 | +57.67% | Nov 15, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +41.90% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +45.84% | Oct 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +45.84% | Sep 9, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +26.13% | Jun 11, 2024 |
| Mizuho | Mizuho | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +34.02% | Apr 9, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +6.42% | Mar 29, 2023 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 3, 2023 |